Matsuya R&D Co.,Ltd
7317株式会社松屋アールアンドディ
Financials
Japan GAAP · consolidated · fiscal year to 2026-03-31- Revenue
- ¥9.8bn
- Net income
- ¥1.5bn
- ROE
- 20.6%
- Equity ratio
- 65.2%
- Dividend / share
- —
- Employees
- 1,552
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | ¥9.8bn | ¥1.5bn | ¥12.5bn | ¥8.1bn | 20.6% | ¥72.5 | ¥1.3bn |
| 2025-03-31 | ¥9.6bn | ¥1.6bn | ¥10.9bn | ¥6.9bn | 25.7% | ¥73.38 | ¥2.6bn |
| 2024-03-31 | ¥8.4bn | ¥1.0bn | ¥9.9bn | ¥5.2bn | 21.3% | ¥45.03 | ¥0.5bn |
| 2023-03-31 | ¥7.2bn | ¥0.4bn | ¥8.7bn | ¥3.8bn | 12.1% | ¥20.17 | ¥0.9bn |
| 2022-03-31 | ¥5.6bn | ¥0.2bn | ¥6.9bn | ¥3.2bn | 5.5% | ¥7.85 | ¥0.1bn |
Indicators
Computed by us from filings · fiscal year to 2026-03-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 20.6 | 88.8 |
| Ordinary margin | 0.2258 | 92.7 |
| Equity ratio, % | 65.2 | 66.5 |
| Revenue growth | 0.0213 | 35.2 |
| Net income growth | -0.0067 | 34.8 |
| Operating cash flow / assets | 0.1017 | 73.7 |
Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥2.3bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥12m, 0.9% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/7317/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/7317/segments/v1/companies/7317/tender-offersOwnership changes
All companies →- 2026-06-29
OMRON HEALTHCARE Co., Ltd. changed its stated purpose for holding Matsuya R&D Co.,Ltd (7317): may_make_proposals -> control, may_make_proposals.
- 2026-06-29
OMRON HEALTHCARE Co., Ltd. raised holdings in Matsuya R&D Co.,Ltd (7317) to 99.98% from 96.41%.
- 2026-06-19
OMRON HEALTHCARE Co., Ltd. states it may make proposals to the management of Matsuya R&D Co.,Ltd (7317) (new compared with its previous filing).
- 2026-06-19
OMRON HEALTHCARE Co., Ltd. raised holdings in Matsuya R&D Co.,Ltd (7317) to 96.41% from 14.97%.
- 2026-06-19
Holdings of OMRON HEALTHCARE Co., Ltd. in Matsuya R&D Co.,Ltd (7317) moved above 20% (14.97% -> 96.41%).
- 2026-06-19
Holdings of OMRON HEALTHCARE Co., Ltd. in Matsuya R&D Co.,Ltd (7317) moved above 33.4% (14.97% -> 96.41%).
- 2026-06-19
Holdings of OMRON HEALTHCARE Co., Ltd. in Matsuya R&D Co.,Ltd (7317) moved above 50% (14.97% -> 96.41%).
- 2026-06-18
individual filer cut holdings in Matsuya R&D Co.,Ltd (7317) to 0.00% from 51.71%, below the 5% threshold.
- 2026-06-18
Holdings of individual filer in Matsuya R&D Co.,Ltd (7317) moved below 10% (51.71% -> 0.00%).
- 2026-06-18
Holdings of individual filer in Matsuya R&D Co.,Ltd (7317) moved below 20% (51.71% -> 0.00%).
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| オムロンヘルスケア株式会社 | 2022-06-01 – 2026-06-25 | +18,681,588 | +90.03pt | ¥1,110 | ¥1,110–1,110 |
| individual filer | 2022-03-18 – 2026-06-15 | -9,380,000 | −48.06pt | ¥961.62 | ¥962–962 |
| individual filer | 2022-03-18 – 2026-06-15 | -1,700,000 | −3.64pt | ¥961.62 | ¥962–962 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/7317/trades.
5% filings
Large shareholding reports on 7317| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-06-29 | OMRON HEALTHCARE Co., Ltd. | 99.98% | +3.57pt | control may make proposals |
| 2026-06-19 | OMRON HEALTHCARE Co., Ltd. | 96.41% | +81.44pt | may make proposals |
| 2026-06-18 | individual filer | 0.00% | −51.71pt | — |
| 2026-05-11 | individual filer | 51.71% | 0.00pt | — |
| 2026-04-27 | individual filer | 51.71% | 0.00pt | — |
| 2026-04-24 | individual filer | 51.71% | −0.04pt | — |
| 2025-12-19 | individual filer | 51.75% | −0.08pt | — |
| 2025-10-17 | individual filer | 51.83% | 0.00pt | — |
| 2025-10-17 | individual filer | 51.83% | 0.00pt | — |
| 2025-09-25 | individual filer | 51.83% | 0.00pt | — |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 1
Held by: MAEDA KOSEN CO., LTD. 7821
Purposes, all holdings and mutual flags via /v1/companies/7317/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-31| Shareholder | Shares | Ratio |
|---|---|---|
| individual holder | 3,600,000 | 16.80% |
| individual holder | 3,600,000 | 16.80% |
| オムロンヘルスケア株式会社 | 3,165,200 | 14.77% |
| ゴトウホールディング株式会社 | 2,000,000 | 9.34% |
| individual holder | 1,880,000 | 8.78% |
| 前田工繊株式会社 | 800,000 | 3.73% |
| モルガン・スタンレーMUFG証券株式会社 | 738,471 | 3.45% |
| 上田八木短資株式会社 | 499,900 | 2.33% |
| JPモルガン証券株式会社 | 373,300 | 1.74% |
| individual holder | 304,600 | 1.42% |
Get this as JSON
GET /v1/companies/7317
GET /v1/companies/7317/financials
GET /v1/companies/7317/details
GET /v1/companies/7317/segments
GET /v1/companies/7317/voting
GET /v1/companies/7317/tender-offers
GET /v1/companies/7317/indicators
GET /v1/companies/7317/earnings-releases
GET /v1/events?ticker=7317
GET /v1/companies/7317/trades
GET /v1/companies/7317/cross-holdings
GET /v1/companies/7317/brief